BioAtla, Inc. releases its Q3 2026 financial results, highlighting advancements in its biological products pipeline and ongoing operational strategies.
| Name | BioAtla, Inc. |
|---|---|
| CIK | 0001826892 |
| Tickers | BCAB |
| Exchanges | OTC |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 851922320 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 858-558-0708 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
BioAtla, Inc. releases its Q3 2026 financial results, highlighting advancements in its biological products pipeline and ongoing operational strategies.
BioAtla, Inc. has received effectiveness for its S-1 registration statement, paving the way for future offerings in the biological products sector.
BioAtla, Inc. files for the resale of up to 8.1 million shares, potentially raising $40 million to support its operations.
BioAtla, Inc. withdraws its Registration Statement on Form S-3, citing ineligibility, impacting its fundraising capabilities in the biological products sector.
BioAtla, Inc. has filed an S-1 registration statement, signaling a potential public offering that could impact its growth and the biological products industry.
BioAtla, Inc. filed an 8-K with the SEC regarding a new $40 million equity purchase agreement with Yorkville. This could impact its financing options.
510 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | 10-Q | 10-Q | 0001193125-26-462306 | 001-39787 | 261555885 | 34 | 9715379 | 1 | 1 | |
| 2026-10-29 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003378 | 333-299532 | 261504254 | 33 | 1711 | ||
| 2026-10-29 | 424B3 | 424B3 | 0001539497-26-002803 | 333-299532 | 261502922 | 33 | 2768722 | |||
| 2026-10-27 | RW | RW | 0001539497-26-002776 | 333-292784 | 261491820 | NE | 19843 | |||
| 2026-10-20 | S-1 | S-1 | 0001539497-26-002711 | 333-299532 | 261470362 | 33 | 11804246 | 1 | 1 | |
| 2026-10-20 | 8-K | 8-K | 1.01,1.02,3.02,9.01 | 0001193125-26-425553 | 001-39787 | 261470347 | 34 | 898918 | 1 | 1 |
| 2026-09-29 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-407817 | 001-39787 | 261424808 | 34 | 306325 | 1 | 1 |
| 2026-09-02 | 4 | 4 | 0001193125-26-380486 | 4863 | ||||||
| 2026-09-02 | 4 | 4 | 0001193125-26-380482 | 8799 | ||||||
| 2026-09-02 | 4 | 4 | 0001193125-26-380479 | 4969 | ||||||
| 2026-08-28 | 8-K | FORM 8-K | 3.01 | 0001539497-26-002373 | 001-39787 | 261333005 | 34 | 195825 | 1 | 1 |
| 2026-08-13 | 10-Q | 10-Q | 0001193125-26-349542 | 001-39787 | 261274688 | 34 | 9477669 | 1 | 1 | |
| 2026-07-16 | 8-K | 8-K | 5.07 | 0001193125-26-306117 | 001-39787 | 261180507 | 34 | 166847 | 1 | 1 |
| 2026-06-05 | 4 | 4 | 0001193125-26-259699 | 6605 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259702 | 10833 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-259689 | 6629 | ||||||
| 2026-06-03 | ARS | ARS | 0001193125-26-255438 | 001-39787 | 261060697 | 34 | 12226603 | |||
| 2026-06-03 | DEFA14A | DEFA14A | 0001193125-26-255434 | 001-39787 | 261060676 | 34 | 2880863 | |||
| 2026-06-03 | DEF 14A | DEF 14A | 0001193125-26-255422 | 001-39787 | 261060643 | 34 | 6583097 | 1 | 1 | |
| 2026-05-15 | 10-Q | 10-Q | 0001193125-26-226631 | 001-39787 | 26987054 | 34 | 8046732 | 1 | 1 | |
| 2026-04-29 | 10-K/A | 10-K/A | 0001193125-26-191493 | 001-39787 | 26915822 | 34 | 3418200 | 1 | 1 | |
| 2026-04-02 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-140053 | 001-39787 | 26833282 | 34 | 179400 | 1 | 1 |
| 2026-03-31 | S-8 | S-8 | 0001193125-26-134492 | 333-294789 | 26822966 | 33 | 847511 | 1 | 1 | |
| 2026-03-31 | 10-K | 10-K | 0001193125-26-134499 | 001-39787 | 26821649 | 34 | 11823255 | 1 | 1 | |
| 2026-03-31 | 8-K | 8-K | 2.02,7.01 | 0001193125-26-134501 | 001-39787 | 26821637 | 34 | 35563172 | 1 | 1 |
| 2026-03-23 | 8-K | 8-K | 5.02,5.07 | 0001193125-26-119698 | 001-39787 | 26782132 | 34 | 169556 | 1 | 1 |
| 2026-03-20 | 424B2 | 424B2 | 0001539497-26-000972 | 333-269148 | 26778241 | 33 | 107535 | |||
| 2026-03-13 | 424B2 | PROSPECTUS SUPPLEMENT NO. 2 | 0001539497-26-000924 | 333-269148 | 26752431 | 33 | 107699 | |||
| 2026-03-12 | 4 | 4 | 0001193125-26-104136 | 4841 | ||||||
| 2026-03-12 | 4 | 4 | 0001193125-26-104134 | 8786 | ||||||
| 2026-03-12 | 4 | 4 | 0001193125-26-104132 | 4818 | ||||||
| 2026-03-09 | 424B2 | 424B2 | 0001539497-26-000894 | 333-269148 | 26732640 | 33 | 107294 | |||
| 2026-03-02 | 4 | 4 | 0001193125-26-085971 | 8673 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085970 | 4705 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085968 | 4822 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085966 | 4728 | ||||||
| 2026-03-02 | DEFA14A | DEFA14A | 0001539497-26-000813 | 001-39787 | 26703507 | 34 | 345483 | |||
| 2026-03-02 | 8-K | FORM 8-K | 2.02,2.05,5.02,7.01,8.01,9.01 | 0001539497-26-000812 | 001-39787 | 26703505 | 34 | 275062 | 1 | 1 |
| 2026-02-11 | DEFM14A | DEFM14A | 0001539497-26-000331 | 001-39787 | 26620673 | 34 | 514267 | |||
| 2026-02-09 | 8-K | 8-K | 8.01 | 0001193125-26-041852 | 001-39787 | 26609441 | 34 | 140979 | 1 | 1 |
| 2026-02-06 | 8-K | 8-K | 3.01,7.01 | 0001193125-26-041367 | 001-39787 | 26608627 | 34 | 166220 | 1 | 1 |
| 2026-01-30 | PREM14A | PREM14A | 0001539497-26-000230 | 001-39787 | 26584511 | 34 | 2457479 | |||
| 2026-01-30 | 8-K | 8-K | 5.03,5.07,7.01,8.01,9.01 | 0001193125-26-031942 | 001-39787 | 26584061 | 34 | 341287 | 1 | 1 |
| 2026-01-16 | S-3 | S-3 | 0001193125-26-015344 | 333-292784 | 26539479 | 33 | 1365282 | 1 | 1 | |
| 2026-01-15 | DEFA14A | DEFA14A | 0001193125-26-013845 | 001-39787 | 26535581 | 34 | 536376 | |||
| 2026-01-12 | 8-K | 8-K | 3.02,5.03,5.07,8.01,9.01 | 0001193125-26-010458 | 001-39787 | 26527057 | 34 | 205923 | 1 | 1 |
| 2025-12-31 | DEFA14A | DEFA14A | 0001193125-25-338402 | 001-39787 | 251617964 | 34 | 17077 | |||
| 2025-12-31 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-25-337646 | 001-39787 | 251615728 | 34 | 186406 | 1 | 1 |
| 2025-12-30 | 8-K | 8-K | 5.07,8.01 | 0001193125-25-337078 | 001-39787 | 251614290 | 34 | 166678 | 1 | 1 |
| 2025-12-05 | DEF 14A | DEF 14A | 0001539497-25-003176 | 001-39787 | 251552940 | 34 | 3619185 | |||
| 2025-12-01 | 4 | 4 | 0001193125-25-304178 | 4893 | ||||||
| 2025-12-01 | 4 | 4 | 0001193125-25-304173 | 4733 | ||||||
| 2025-12-01 | 4 | 4 | 0001193125-25-304171 | 8677 | ||||||
| 2025-12-01 | 4 | 4 | 0001193125-25-304170 | 4828 | ||||||
| 2025-11-24 | PRE 14A | PRE 14A | 0001193125-25-292058 | 001-39787 | 251509619 | 34 | 381917 | |||
| 2025-11-21 | 424B5 | 424B5 | 0001193125-25-290676 | 333-269148 | 251504682 | 33 | 579324 | |||
| 2025-11-21 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-25-290474 | 001-39787 | 251504543 | 34 | 1709308 | 1 | 1 |
| 2025-11-13 | 10-Q | 10-Q | 0001193125-25-280435 | 001-39787 | 251479565 | 34 | 8356062 | 1 | 1 | |
| 2025-11-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-280141 | 001-39787 | 251478385 | 34 | 343808 | 1 | 1 |
| 2025-10-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002060873-25-000004 | 005-91930 | 251393490 | 34 | 7160 | |||
| 2025-09-22 | 8-K | 8-K | 8.01 | 0001193125-25-211305 | 001-39787 | 251330127 | 34 | 150237 | 1 | 1 |
| 2025-09-02 | 4 | 4 | 0000950170-25-112618 | 8678 | ||||||
| 2025-09-02 | 4 | 4 | 0000950170-25-112616 | 4785 | ||||||
| 2025-09-02 | 4 | 4 | 0000950170-25-112615 | 4734 | ||||||
| 2025-09-02 | 4 | 4 | 0000950170-25-112614 | 4764 | ||||||
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-105220 | 001-39787 | 251195160 | 34 | 9384619 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-105000 | 001-39787 | 251193953 | 34 | 327600 | 1 | 1 |
| 2025-06-20 | 8-K | 8-K | 5.02,5.07 | 0000950170-25-088499 | 001-39787 | 251061373 | 34 | 176043 | 1 | 1 |
| 2025-06-18 | 4 | 4 | 0000950170-25-088065 | 4701 | ||||||
| 2025-06-18 | 4 | 4 | 0000950170-25-088064 | 4723 | ||||||
| 2025-06-18 | 4 | 4 | 0000950170-25-088063 | 4850 | ||||||
| 2025-06-18 | 4 | 4 | 0000950170-25-088062 | 4711 | ||||||
| 2025-06-18 | 4 | 4 | 0000950170-25-088061 | 4611 | ||||||
| 2025-06-18 | 4 | 4 | 0000950170-25-088060 | 4747 | ||||||
| 2025-06-03 | 4 | 4 | 0000950170-25-080994 | 8679 | ||||||
| 2025-06-03 | 4 | 4 | 0000950170-25-080990 | 4733 | ||||||
| 2025-06-03 | 4 | 4 | 0000950170-25-080991 | 4898 | ||||||
| 2025-06-03 | 4 | 4 | 0000950170-25-080980 | 4919 | ||||||
| 2025-05-20 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001636587-25-000025 | 005-91930 | 25967932 | 34 | 11990 | |||
| 2025-05-16 | 8-K | 8-K | 3.01 | 0000950170-25-073688 | 001-39787 | 25960395 | 34 | 157736 | 1 | 1 |
| 2025-05-16 | 424B3 | 424B3 | 0001193125-25-121711 | 333-287011 | 25959620 | 33 | 125253 | |||
| 2025-05-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001604 | 333-287011 | 25948282 | 33 | 1710 | ||
| 2025-05-12 | CORRESP | filename1.htm | 0001193125-25-117883 | 14624 | ||||||
| 2025-05-09 | UPLOAD | filename1.pdf | 0000000000-25-004982 | 333-287011 | 40065 | |||||
| 2025-05-06 | S-3 | S-3 | 0001193125-25-113919 | 333-287011 | 25918379 | 33 | 229572 | |||
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-064594 | 001-39787 | 25918160 | 34 | 7134918 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-064415 | 001-39787 | 25917093 | 34 | 311064 | 1 | 1 |
| 2025-04-25 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-001988 | 005-91930 | 25872415 | 34 | 9459 | |||
| 2025-04-24 | ARS | ARS | 0000950170-25-058047 | 001-39787 | 25867459 | 34 | 2144638 | |||
| 2025-04-24 | DEFA14A | DEFA14A | 0000950170-25-058024 | 001-39787 | 25867380 | 34 | 1305718 | |||
| 2025-04-24 | DEF 14A | DEF 14A | 0000950170-25-058011 | 001-39787 | 25867308 | 34 | 5563980 | 1 | 1 | |
| 2025-03-28 | S-8 | S-8 | 0000950170-25-046227 | 333-286196 | 25781282 | 33 | 666462 | |||
| 2025-03-28 | 10-K | 10-K | 0000950170-25-046217 | 001-39787 | 25780785 | 34 | 10797884 | 1 | 1 | |
| 2025-03-27 | 8-K | 8-K | 2.02,2.05,9.01 | 0000950170-25-046065 | 001-39787 | 25779342 | 34 | 334312 | 1 | 1 |
| 2025-03-18 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002060873-25-000001 | 005-91930 | 25747096 | 34 | 7411 | |||
| 2025-03-14 | 8-K | 8-K | 5.02 | 0000950170-25-039400 | 001-39787 | 25739924 | 34 | 154680 | 1 | 1 |
| 2025-03-13 | 4 | 4 | 0000950170-25-038748 | 4874 | ||||||
| 2025-03-13 | 4 | 4 | 0000950170-25-038746 | 8769 | ||||||
| 2025-03-13 | 4 | 4 | 0000950170-25-038745 | 4853 | ||||||
| 2025-03-13 | 4 | 4 | 0000950170-25-038741 | 4823 | ||||||
| 2025-02-24 | 4 | 4 | 0000950170-25-025969 | 8683 | ||||||
| 2025-02-24 | 4 | 4 | 0000950170-25-025968 | 4739 | ||||||
| 2025-02-24 | 4 | 4 | 0000950170-25-025967 | 4904 | ||||||
| 2025-02-24 | 4 | 4 | 0000950170-25-025962 | 4924 | ||||||
| 2025-02-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000807 | 005-91930 | 25606532 | 34 | 10603 | |||
| 2025-02-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-016381 | 005-91930 | 25602512 | 34 | 9882 | |||
| 2025-02-07 | 8-K | 8-K | 3.01 | 0000950170-25-016321 | 001-39787 | 25602165 | 34 | 153156 | 1 | 1 |
| 2025-01-24 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-005973 | 005-91930 | 25554095 | 34 | 15168 | |||
| 2024-12-20 | 424B5 | 424B5 | 0001193125-24-283216 | 333-262528 | 241568712 | 33 | 489813 | |||
| 2024-12-20 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-24-283212 | 001-39787 | 241568660 | 34 | 531331 | 1 | 1 |
| 2024-12-20 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-282547 | 001-39787 | 241565297 | 34 | 17919087 | 1 | 1 |
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 3 | 0001214659-24-019104 | 005-91930 | 241461363 | 34 | 84008 | |||
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123506 | 001-39787 | 241436942 | 34 | 6080620 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-123281 | 001-39787 | 241435501 | 34 | 303188 | 1 | 1 |
| 2024-10-02 | SC 13D/A | AMENDMENT NO. 6 TO SCHEDULE 13D | 0001213900-24-084675 | 005-91930 | 241347862 | 34 | 175326 | |||
| 2024-09-23 | 8-K | 8-K | 1.01,9.01 | 0001193125-24-223282 | 001-39787 | 241314647 | 34 | 1035281 | 1 | 1 |
| 2024-09-06 | SC 13D/A | AMENDMENT NO. 5 TO SCHEDULE 13D | 0001213900-24-076577 | 005-91930 | 241285108 | 34 | 178739 | |||
| 2024-09-03 | 4 | 4 | 0000950170-24-102925 | 4720 | ||||||
| 2024-09-03 | 4 | 4 | 0000950170-24-102924 | 4738 | ||||||
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-094164 | 001-39787 | 241189445 | 34 | 5935967 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-093888 | 001-39787 | 241188149 | 34 | 292959 | 1 | 1 |
| 2024-08-07 | SC 13G | BCAB_SC13G.htm | 0001273087-24-000082 | 005-91930 | 241184221 | 34 | 81716 | |||
| 2024-08-01 | 4 | 4 | 0000950170-24-089427 | 4720 | ||||||
| 2024-08-01 | 4 | 4 | 0000950170-24-089419 | 4738 | ||||||
| 2024-07-08 | SC 13G/A | us09077b1044_070824.txt | 0001086364-24-008160 | 005-91930 | 241105158 | 34 | 12752 | |||
| 2024-07-01 | 4 | 4 | 0000950170-24-079916 | 4720 | ||||||
| 2024-07-01 | 4 | 4 | 0000950170-24-079915 | 4738 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073683 | 4718 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073681 | 4618 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073678 | 4757 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073675 | 4857 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073662 | 4731 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073659 | 4708 | ||||||
| 2024-06-13 | 8-K | 8-K | 5.07 | 0000950170-24-073139 | 001-39787 | 241042121 | 34 | 158700 | 1 | 1 |
| 2024-05-31 | 4 | 4 | 0000950170-24-067579 | 4720 | ||||||
| 2024-05-31 | 4 | 4 | 0000950170-24-067577 | 4738 | ||||||
| 2024-05-17 | 8-K | 8-K | 8.01 | 0000950170-24-061616 | 001-39787 | 24959540 | 34 | 147535 | 1 | 1 |
| 2024-05-14 | 10-Q | 10-Q | 0000950170-24-059757 | 001-39787 | 24945515 | 34 | 5532181 | 1 | 1 | |
| 2024-05-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-059508 | 001-39787 | 24944196 | 34 | 274334 | 1 | 1 |
| 2024-05-01 | 4 | 4 | 0000950170-24-051521 | 4737 | ||||||
| 2024-05-01 | 4 | 4 | 0000950170-24-051520 | 4719 | ||||||
| 2024-04-24 | 8-K | 8-K | 5.03,9.01 | 0000950170-24-047595 | 001-39787 | 24870753 | 34 | 446061 | 1 | 1 |
| 2024-04-24 | ARS | ARS | 0000950170-24-047582 | 001-39787 | 24870650 | 34 | 997447 | |||
| 2024-04-24 | DEFA14A | DEFA14A | 0000950170-24-047568 | 001-39787 | 24870539 | 34 | 1418928 | |||
| 2024-04-24 | DEF 14A | DEF 14A | 0000950170-24-047562 | 001-39787 | 24870499 | 34 | 2874113 | |||
| 2024-04-16 | SC 13D/A | AMENDMENT NO. 4 TO SCHEDULE 13D | 0001213900-24-033175 | 005-91930 | 24846235 | 34 | 180267 | |||
| 2024-04-01 | 4 | 4 | 0000950170-24-039480 | 4719 | ||||||
| 2024-04-01 | 4 | 4 | 0000950170-24-039478 | 4737 | ||||||
| 2024-03-26 | S-8 | S-8 | 0000950170-24-036571 | 333-278247 | 24784679 | 33 | 601016 | |||
| 2024-03-26 | 10-K | 10-K | 0000950170-24-036548 | 001-39787 | 24784543 | 34 | 9197336 | 1 | 1 | |
| 2024-03-26 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-036395 | 001-39787 | 24783428 | 34 | 302073 | 1 | 1 |
| 2024-03-01 | 4 | FORM 4 SUBMISSION | 0001209191-24-004161 | 4947 | ||||||
| 2024-03-01 | 4 | FORM 4 SUBMISSION | 0001209191-24-004156 | 4965 | ||||||
| 2024-02-21 | 8-K | 8-K | 5.02 | 0000950170-24-017881 | 001-39787 | 24659272 | 34 | 162056 | 1 | 1 |
| 2024-02-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-003511 | 5057 | ||||||
| 2024-02-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-003509 | 5063 | ||||||
| 2024-02-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-003508 | 5027 | ||||||
| 2024-02-20 | 4 | FORM 4 SUBMISSION | 0001209191-24-003507 | 8973 | ||||||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 2 | 0001214659-24-002863 | 005-91930 | 24637363 | 34 | 84571 | |||
| 2024-02-12 | 8-K | 8-K | 8.01 | 0000950170-24-013807 | 001-39787 | 24619757 | 34 | 153163 | 1 | 1 |
| 2024-02-09 | SC 13G/A | BIOATLA, INC. JAY SHORT 13G/A | 0001068238-24-000042 | 005-91930 | 24615880 | 34 | 74513 | |||
| 2024-02-06 | SC 13G/A | BIOATLA, INC. | 0000902664-24-001098 | 005-91930 | 24600054 | 34 | 99339 | |||
| 2024-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-24-002594 | 4947 | ||||||
| 2024-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-24-002592 | 4964 | ||||||
| 2024-01-29 | SC 13G | us09077b1044_012924.txt | 0001086364-24-005524 | 005-91930 | 24574931 | 34 | 13226 | |||
| 2024-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-24-001929 | 4426 | ||||||
| 2024-01-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-004912 | 001-39787 | 24521902 | 34 | 17735686 | 1 | 1 |
| 2024-01-08 | 8-K | 8-K | 5.03,9.01 | 0001193125-24-004539 | 001-39787 | 24521006 | 34 | 321781 | 1 | 1 |
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000603 | 5046 | ||||||
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000601 | 5033 | ||||||
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000598 | 4947 | ||||||
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000596 | 4964 | ||||||
| 2023-12-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-059720 | 4802 | ||||||
| 2023-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-059387 | 8908 | ||||||
| 2023-12-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-059284 | 5043 | ||||||
| 2023-12-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-059164 | 5129 | ||||||
| 2023-12-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-293959 | 001-39787 | 231483043 | 34 | 190319 | 1 | 1 |
| 2023-12-04 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-288019 | 001-39787 | 231461463 | 34 | 2792830 | 1 | 1 |
| 2023-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-057086 | 4866 | ||||||
| 2023-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-057084 | 4883 | ||||||
| 2023-11-07 | 10-Q | 10-Q | 0000950170-23-060389 | 001-39787 | 231384981 | 34 | 6591990 | 1 | 1 | |
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-060210 | 001-39787 | 231383563 | 34 | 334575 | 1 | 1 |
| 2023-11-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-054075 | 8831 | ||||||
| 2023-11-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-054073 | 4914 | ||||||
| 2023-11-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-054063 | 4883 | ||||||
| 2023-11-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-054062 | 4866 | ||||||
| 2023-11-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-054061 | 4917 | ||||||
| 2023-10-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-051692 | 4965 | ||||||
| 2023-10-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-051691 | 4952 | ||||||
| 2023-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-051187 | 8831 | ||||||
| 2023-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-051184 | 4914 | ||||||
| 2023-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-051182 | 4917 | ||||||
| 2023-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-051180 | 4866 | ||||||
| 2023-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-051178 | 4883 | ||||||
| 2023-09-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-049347 | 4345 | ||||||
| 2023-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-048035 | 5049 | ||||||
| 2023-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-048034 | 4917 | ||||||
| 2023-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-048033 | 4866 | ||||||
| 2023-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-048032 | 4883 | ||||||
| 2023-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-048031 | 8831 | ||||||
| 2023-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-044052 | 8831 | ||||||
| 2023-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-044051 | 5049 | ||||||
| 2023-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-044049 | 5018 | ||||||
| 2023-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-044048 | 4866 | ||||||
| 2023-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-044046 | 4917 | ||||||
| 2023-08-01 | 10-Q | 10-Q | 0000950170-23-036554 | 001-39787 | 231132621 | 34 | 7388458 | 1 | 1 | |
| 2023-08-01 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-036440 | 001-39787 | 231131556 | 34 | 372153 | 1 | 1 |
| 2023-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-041218 | 4952 | ||||||
| 2023-07-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-041217 | 4964 | ||||||
| 2023-07-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-040669 | 8831 | ||||||
| 2023-07-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-040667 | 4917 | ||||||
| 2023-07-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-040666 | 4866 | ||||||
| 2023-07-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-040664 | 4883 | ||||||
| 2023-07-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-040662 | 4914 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037549 | 7683 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037548 | 5422 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037547 | 5399 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037546 | 5548 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037545 | 5309 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037544 | 5409 | ||||||
| 2023-06-14 | 8-K | 8-K | 5.07 | 0000950170-23-028007 | 001-39787 | 231014865 | 34 | 186063 | 1 | 1 |
| 2023-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-033473 | 8830 | ||||||
| 2023-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-033472 | 4913 | ||||||
| 2023-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-033471 | 4882 | ||||||
| 2023-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-033470 | 4865 | ||||||
| 2023-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-033469 | 4916 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029632 | 4962 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029631 | 4951 | ||||||
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021358 | 001-39787 | 23912005 | 34 | 6256772 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-021212 | 001-39787 | 23910952 | 34 | 347906 | 1 | 1 |
| 2023-05-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-026662 | 8830 | ||||||
| 2023-05-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-026660 | 4913 | ||||||
| 2023-05-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-026659 | 4882 | ||||||
| 2023-05-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-026658 | 4865 | ||||||
| 2023-05-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-026656 | 4916 | ||||||
| 2023-04-27 | SC 13G | BIOATLA, INC. | 0000902664-23-002714 | 005-91930 | 23853706 | 34 | 111640 | |||
| 2023-04-24 | DEFA14A | DEFA14A | 0000950170-23-014139 | 001-39787 | 23840924 | 34 | 1853392 | |||
| 2023-04-24 | ARS | ARS | 0000950170-23-014137 | 001-39787 | 23840916 | 34 | 2513126 | |||
| 2023-04-24 | DEF 14A | DEF 14A | 0000950170-23-014136 | 001-39787 | 23840905 | 34 | 3117257 | |||
| 2023-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-022431 | 8830 | ||||||
| 2023-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-022430 | 4913 | ||||||
| 2023-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-022428 | 4882 | ||||||
| 2023-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-022427 | 4923 | ||||||
| 2023-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-022426 | 4916 | ||||||
| 2023-03-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-021720 | 8824 | ||||||
| 2023-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-23-021543 | 4912 | ||||||
| 2023-03-23 | S-8 | S-8 | 0000950170-23-009555 | 333-270802 | 23757090 | 33 | 720869 | |||
| 2023-03-23 | 10-K | 10-K | 0000950170-23-009551 | 001-39787 | 23757003 | 34 | 10832067 | 1 | 1 | |
| 2023-03-23 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-009469 | 001-39787 | 23756140 | 34 | 431758 | 1 | 1 |
| 2023-03-10 | 8-K | 8-K | 7.01 | 0000950170-23-007213 | 001-39787 | 23723137 | 34 | 161165 | 1 | 1 |
| 2023-03-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-014295 | 11401 | ||||||
| 2023-03-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-014294 | 7494 | ||||||
| 2023-03-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-014292 | 7484 | ||||||
| 2023-03-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-014290 | 7479 | ||||||
| 2023-03-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-014288 | 7453 | ||||||
| 2023-02-27 | SC 13G/A | BIOATLA - JAY SHORT SCHEDULE 13G/A | 0001068238-23-000043 | 005-91930 | 23675036 | 34 | 75294 | |||
| 2023-02-27 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-049760 | 001-39787 | 23670167 | 34 | 160582 | 1 | 1 |
| 2023-02-15 | 8-K | 8-K | 5.02 | 0000950170-23-002910 | 001-39787 | 23635788 | 34 | 182747 | 1 | 1 |
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-23-002392 | 005-91930 | 23628396 | 34 | 84592 | |||
| 2023-02-14 | SC 13G/A | schedule13ga.htm | 0000929638-23-000564 | 005-91930 | 23627758 | 34 | 106089 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015457 | 005-91930 | 23602636 | 34 | 12886 | |||
| 2023-02-06 | SC 13G/A | SEC SCHEDULE 13G | 0000846087-23-000082 | 005-91930 | 23590074 | 34 | 32760 | |||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006438 | 8798 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006435 | 4882 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006433 | 4884 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006430 | 4850 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006424 | 4876 | ||||||
| 2023-01-17 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-01-17 16:00:00 | 9999999995-23-000119 | 333-269148 | 23532845 | 33 | 1668 | ||
| 2023-01-13 | CORRESP | filename1.htm | 0001193125-23-008334 | 13319 | ||||||
| 2023-01-13 | UPLOAD | filename1.pdf | 0000000000-23-000388 | 40122 | ||||||
| 2023-01-09 | SC 13D/A | SC 13D/A | 0001193125-23-004819 | 005-91930 | 23518758 | 34 | 159751 | |||
| 2023-01-06 | S-3 | S-3 | 0001193125-23-003572 | 333-269148 | 23515337 | 33 | 852467 | |||
| 2023-01-06 | 8-K | 8-K | 1.01,9.01 | 0001193125-23-003550 | 001-39787 | 23515215 | 34 | 424476 | 1 | 1 |
| 2023-01-06 | 424B5 | 424B5 | 0001193125-23-003545 | 333-262528 | 23515174 | 33 | 311835 | |||
| 2023-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-000323 | 8798 | ||||||
| 2023-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-000318 | 4884 | ||||||
| 2023-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-000316 | 4881 | ||||||
| 2023-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-000311 | 4850 | ||||||
| 2023-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-000305 | 4876 | ||||||
| 2022-12-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-062000 | 4314 | ||||||
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-059271 | 8800 | ||||||
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-059269 | 5018 | ||||||
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-059265 | 4987 | ||||||
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-059264 | 4886 | ||||||
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-059263 | 5013 | ||||||
| 2022-11-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-058723 | 4314 | ||||||
| 2022-11-07 | 8-K | 8-K | 1.01,9.01 | 0001193125-22-279214 | 001-39787 | 221366327 | 34 | 420386 | 1 | 1 |
| 2022-11-07 | 424B5 | 424B5 | 0001193125-22-278766 | 333-262528 | 221364417 | 33 | 359454 | |||
| 2022-11-04 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-277328 | 001-39787 | 221360054 | 34 | 3324528 | 1 | 1 |
| 2022-11-04 | 10-Q | 10-Q | 0000950170-22-022036 | 001-39787 | 221360048 | 34 | 8140603 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-021833 | 001-39787 | 221357845 | 34 | 397645 | 1 | 1 |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-055169 | 8799 | ||||||
| 2022-11-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-055168 | 4882 | ||||||
| 2022-11-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-055167 | 4851 | ||||||
| 2022-11-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-055166 | 4885 | ||||||
| 2022-11-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-055165 | 4816 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052556 | 4816 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052567 | 8799 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052565 | 4851 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052558 | 4885 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052555 | 4882 | ||||||
| 2022-09-21 | 8-K | 8-K | 5.02,9.01 | 0000950170-22-018700 | 001-39787 | 221255092 | 34 | 383650 | 1 | 1 |
| 2022-09-20 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-050774 | 3862 | ||||||
| 2022-09-20 | 3/A | FORM 3/A SUBMISSION | 0001209191-22-050771 | 3682 | ||||||
| 2022-09-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-050147 | 5834 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048367 | 8799 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048366 | 4816 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048364 | 4882 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048363 | 4885 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048362 | 4851 | ||||||
| 2022-08-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-045810 | 8750 | ||||||
| 2022-08-09 | 10-Q | 10-Q | 0000950170-22-016149 | 001-39787 | 221149270 | 34 | 7227197 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016024 | 001-39787 | 221148137 | 34 | 385042 | 1 | 1 |
| 2022-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-043744 | 8799 | ||||||
| 2022-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-043743 | 4882 | ||||||
| 2022-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-043742 | 4816 | ||||||
| 2022-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-043741 | 4885 | ||||||
| 2022-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-043740 | 4851 | ||||||
| 2022-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-040328 | 8799 | ||||||
| 2022-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-040327 | 4882 | ||||||
| 2022-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-040325 | 4816 | ||||||
| 2022-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-040322 | 4885 | ||||||
| 2022-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-040318 | 4851 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-038959 | 10924 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0000899243-22-023587 | 3619 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-038185 | 8586 | ||||||
| 2022-06-17 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-038182 | 5951 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-038177 | 5374 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-038172 | 5501 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-038170 | 5352 | ||||||
| 2022-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-038169 | 5362 | ||||||
| 2022-06-17 | 8-K | 8-K | 5.07 | 0000950170-22-011774 | 001-39787 | 221022520 | 34 | 183774 | 1 | 1 |
| 2022-06-10 | SC 13G/A | filing.txt | 0000315066-22-001622 | 005-91930 | 221008002 | 34 | 7852 | |||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-035350 | 8579 | ||||||
| 2022-06-06 | 8-K | 8-K | 5.02 | 0001193125-22-168316 | 001-39787 | 22998104 | 34 | 139226 | 1 | 1 |
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034323 | 10569 | ||||||
| 2022-06-03 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-034318 | 4656 | ||||||
| 2022-06-03 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-034311 | 5379 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034305 | 4815 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034303 | 4881 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034299 | 4884 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034296 | 4850 | ||||||
| 2022-05-18 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-22-153165,2022-05-18 | 9999999995-22-001521 | 333-262528 | 22941068 | 33 | 1681 | ||
| 2022-05-17 | POS AM | POS AM | 0001193125-22-153165 | 333-262528 | 22936021 | 33 | 76511 | |||
| 2022-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-027637 | 4936 | ||||||
| 2022-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-027631 | 4870 | ||||||
| 2022-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-027629 | 4939 | ||||||
| 2022-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-027627 | 4905 | ||||||
| 2022-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-027626 | 7774 | ||||||
| 2022-05-05 | 10-Q | 10-Q | 0000950170-22-007871 | 001-39787 | 22896913 | 34 | 6113286 | 1 | 1 | |
| 2022-05-04 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-007371 | 001-39787 | 22891417 | 34 | 343252 | 1 | 1 |
| 2022-04-28 | SC 13G | p425220sc13g.htm | 0001214659-22-005979 | 005-91930 | 22866313 | 34 | 91172 | |||
| 2022-04-25 | DEFA14A | DEFA14A | 0001193125-22-117688 | 001-39787 | 22850141 | 34 | 81786 | |||
| 2022-04-25 | DEF 14A | DEF 14A | 0001193125-22-117564 | 001-39787 | 22849806 | 34 | 681973 | |||
| 2022-04-11 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-101666 | 001-39787 | 22819813 | 34 | 7132152 | 1 | 1 |
| 2022-04-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-022745 | 4936 | ||||||
| 2022-04-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-022744 | 4870 | ||||||
| 2022-04-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-022743 | 4939 | ||||||
| 2022-04-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-022742 | 4905 | ||||||
| 2022-04-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-022741 | 7774 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016382 | 4936 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016374 | 4932 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016367 | 4939 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016363 | 4905 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016353 | 7774 | ||||||
| 2022-03-01 | 424B3 | 424B3 | 0000950170-22-002383 | 333-260440 | 22693561 | 33 | 5784106 | |||
| 2022-03-01 | S-8 | S-8 | 0001193125-22-058789 | 333-263120 | 22692934 | 33 | 72122 | |||
| 2022-03-01 | POS AM | POS AM | 0001193125-22-058761 | 333-262528 | 22692832 | 33 | 255448 | |||
| 2022-02-28 | 10-K | 10-K | 0000950170-22-002303 | 001-39787 | 22690082 | 34 | 16736594 | 1 | 1 | |
| 2022-02-28 | POSASR | POSASR | 0001193125-22-057854 | 333-262528 | 22689345 | 33 | 303732 | |||
| 2022-02-25 | 8-K | 8-K | 5.02 | 0001193125-22-054400 | 001-39787 | 22679957 | 34 | 146094 | 1 | 1 |
| 2022-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-012946 | 5541 | ||||||
| 2022-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-012944 | 5554 | ||||||
| 2022-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-012942 | 5539 | ||||||
| 2022-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-012940 | 5533 | ||||||
| 2022-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-012938 | 5509 | ||||||
| 2022-02-14 | SC 13G/A | JAY SHORT 13G | 0001068238-22-000045 | 005-91930 | 22631894 | 34 | 97156 | |||
| 2022-02-14 | SC 13G/A | schedule13g.htm | 0000929638-22-000479 | 005-91930 | 22630194 | 34 | 107864 | |||
| 2022-02-11 | SC 13G/A | SC 13G/A BIOATLA | 0000078003-22-000012 | 005-91930 | 22622245 | 34 | 64010 | |||
| 2022-02-11 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-020460 | 005-91930 | 22620683 | 34 | 35316 | |||
| 2022-02-09 | SC 13G | SCHEDULE 13G | 0001104659-22-016639 | 005-91930 | 22606641 | 34 | 12857 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-000769 | 005-91930 | 22604069 | 34 | 8383 | |||
| 2022-02-08 | SC 13G/A | AMENDMENT #1 | 0000908834-22-000047 | 005-91930 | 22599900 | 34 | 334558 | |||
| 2022-02-04 | S-3ASR | S-3ASR | 0001193125-22-028341 | 333-262528 | 22593330 | 33 | 736069 | |||
| 2022-02-04 | SC 13G | SEC SCHEDULE 13G | 0001678858-22-000117 | 005-91930 | 22591279 | 34 | 37784 | |||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006516 | 5512 | ||||||
| 2022-02-02 | 3 | FORM 3 SUBMISSION | 0001209191-22-006509 | 6832 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006504 | 5017 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006503 | 5011 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006500 | 4884 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006497 | 4850 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006493 | 7719 | ||||||
| 2022-01-11 | 8-K | 8-K | 1.01,9.01 | 0000950170-22-000220 | 001-39787 | 22522169 | 34 | 196992 | 1 | 1 |
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-002043 | 4938 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-002042 | 4871 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-002040 | 4937 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-002039 | 4906 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-002038 | 7775 | ||||||
| 2021-12-21 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-363150 | 001-39787 | 211507004 | 34 | 180469 | 1 | 1 |
| 2021-12-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-068388 | 19034 |
One latest value per concept from companyfacts (245 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 32.32M | 2021-08-13 | 2021 | Q2 | 10-Q | 2021-08-13 | 0000950170-21-001443 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 18.70M | 2025-06-30 | 2025 | FY | 10-K/A | 2026-04-29 | 0001193125-26-191493 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 555,106 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-03 | 0001193125-26-255422 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 550,294 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-03 | 0001193125-26-255422 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 866,130 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-03 | 0001193125-26-255422 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 879,248 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-03 | 0001193125-26-255422 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 6.88 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-03 | 0001193125-26-255422 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 925.4 | 2026-10-19 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 925.4 | 2026-10-19 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 10.64M | 2026-10-19 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-19 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-10-19 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 18.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 12.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | AccountsPayableCurrentAndNoncurrent | Accounts Payable | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001193125-25-280435 | |
| us-gaap | AccountsPayableOtherCurrent | Accounts Payable, Other, Current | USD | 300,000 | 2026-06-30 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 5.80M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 37,000 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 5.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 515.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | USD | 534,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 764,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | -6.85M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | AllocatedShareBasedCompensationExpenseNetOfTax | Share-based Payment Arrangement, Expense, after Tax | USD | 294,000 | 2024-01-01 | 2024-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 358,801 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 4.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | Assets | Assets | USD | 1.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 946,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134499 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 576,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 576,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -6.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 4.35 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 457,997 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 350.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 1.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 1.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | DebtInstrumentDecreaseForgiveness | Debt Instrument, Decrease, Forgiveness | USD | 700,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 |
| us-gaap | DebtInstrumentFairValue | Debt Instrument, Fair Value Disclosure | USD | 4.10M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-13 | 0000950170-21-001443 |
| us-gaap | DeferredGainOnSaleOfProperty | Deferred Gain on Sale of Property | USD | 1.49M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 4.16M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 2.43M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 117.09M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134499 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 1.16M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 51.46M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 81,000 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 15.42M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation | USD | 556,000 | 2024-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 3.63M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent | USD | 504,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 115.93M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 1.16M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 1.16M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxLiabilitiesRegulatoryAssets | Deferred Tax Liabilities, Regulatory Assets | USD | 75,000 | 2024-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityBadDebtReserveForTaxPurposesOfQualifiedLender | Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Bad Debt Reserve for Tax Purposes of Qualified Lender | USD | 4.16M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 120,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | DerivativeAssetFairValueGrossLiability | Derivative Asset, Fair Value, Gross Liability | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 | |
| us-gaap | DerivativeFairValueOfDerivativeAsset | Derivative Asset, Fair Value, Gross Asset | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 | |
| us-gaap | DerivativeFloorPrice | Derivative, Floor Price | USD/XUA | 0.23 | 2025-11-30 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134499 | |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -8.56 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.65 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007871 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -8.56 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.215 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.016 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.021 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability | Embedded Derivative, Fair Value of Embedded Derivative Liability | USD | 0 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 | |
| us-gaap | EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net | USD | 1.58M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | -3.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -185,000 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 9.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability | Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability | USD | -2.13M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 12.83M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -12.52M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 981,000 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | -132,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-28 | 0000950170-25-046217 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 3.79M | 2024-01-01 | 2024-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 403,000 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -1.28M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 2.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | 300,000 | 2026-01-01 | 2026-06-30 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 2.00M | 2026-01-01 | 2026-06-30 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | IncreaseDecreaseInAccruedInterestReceivableNet | Increase (Decrease) in Accrued Interest Receivable, Net | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | 348,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -525,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 1,123 | 2026-04-01 | 2026-06-30 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | InterestExpense | Interest Expense | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | InterestExpenseRelatedParty | Interest Expense, Related Party | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 65,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 7.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 1.53M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001193125-25-280435 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 753,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | Liabilities | Liabilities | USD | 44.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 20.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders | USD | 19,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 111,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 0 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-06 | 0000950170-25-064594 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -6.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -13.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | NetIncomeLossAttributableToRedeemableNoncontrollingInterest | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest | USD | -28.73M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -72.01M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | NumberOfSegment | 1 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 24.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -17.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.70M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 4.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 5.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 4.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 731,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 6.09M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.55M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 1.69M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 1.64M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 845,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 370,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 1.20M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.09 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 112,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 163,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | OtherExpenses | Other Expenses | USD | 39,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | OtherLongTermDebtNoncurrent | Other Long-term Debt, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 | |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0000950170-21-004617 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 3.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | PaymentsForRepurchaseOfInitialPublicOffering | Payments for Repurchase of Initial Public Offering | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 500,000 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 700,000 | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 289,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 3.32M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 |
| us-gaap | PaymentsToAcquireMachineryAndEquipment | Payments to Acquire Machinery and Equipment | USD | 0 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-06 | 0000950170-25-064594 |
| us-gaap | PaymentsToMinorityShareholders | Payments to Noncontrolling Interests | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | PreferredStockDividendRatePercentage | Preferred Stock, Dividend Rate, Percentage | pure | 0.1 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 370,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 111,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134499 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | ProceedsFromIssuanceOfOtherLongTermDebt | Proceeds from Issuance of Other Long-term Debt | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | ProceedsFromSaleOfOtherPropertyPlantAndEquipment | Proceeds from Sale of Other Property, Plant, and Equipment | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | PropertyPlantAndEquipmentAdditions | Property, Plant and Equipment, Additions | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 5.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 975,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 9.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | RestrictedCashEquivalents | Restricted Cash Equivalents | USD | 42.30M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123506 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 556,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0000950170-25-105220 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 500,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -559.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer | Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer | USD | 6.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | Revenues | Revenues | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060389 |
| us-gaap | SettlementLiabilitiesCurrent | Settlement Liabilities, Current | USD | 4.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 2.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134499 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.953 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134499 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.037 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001193125-26-134499 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 496,074 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 25.95 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 182.83M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 112,367 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 170,836 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 371,439 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 479,543 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 0 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | shares | 170,836 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 991.50M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 6.27M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 26.76 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 3.64B | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 6.27M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 13.82 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 1.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 1.31M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent | Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | pure | 0.15 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-04 | 0000950170-22-022036 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 40 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 21.64 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 37.86 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 69.5 | 2025-11-30 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 1.49M | 2022-06-30 | 2023 | Q2 | 10-Q | 2023-08-01 | 0000950170-23-036554 | |
| us-gaap | StockGrantedDuringPeriodValueSharebasedCompensationForfeited | Shares Granted, Value, Share-based Payment Arrangement, Forfeited | USD | 25,000 | 2019-11-01 | 2019-11-30 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -43.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | -43.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 50 | 2026-04-06 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 3,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 61.68M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0000950170-22-002303 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 140,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-23 | 0000950170-23-009551 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 11.80M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 5.35M | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | |||
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions | USD | 947,000 | 2024-01-01 | 2024-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 717,000 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 52,000 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | UnrecognizedTaxBenefitsPeriodIncreaseDecrease | Unrecognized Tax Benefits, Period Increase (Decrease) | USD | 1.55M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-26 | 0000950170-24-036548 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 13.30M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-20 | 0001539497-26-002711 | ||
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 295,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 1.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 37.32M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007871 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 1.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-16 | 0001193125-26-462306 |